AbCellera Biologics (ABCL) vs Parabilis Medicines (PBLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Parabilis Medicines is the larger company by market cap ($3.44 billion vs $3.16 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ABCL | PBLS |
|---|---|---|
| Share price | $9.69 | $27.44 |
| Market cap | $3.16B | $3.44B |
| 1-day change | -7.45% | -0.67% |
| YTD return | +183.33% | — |
| 1-year return | +176.07% | — |
| 5-year return | -30.74% | — |
| EPS (TTM) | $-0.48 | $-3.62 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $75.13M | — |
| Revenue growth (YoY) | +160.56% | — |
| Net income (latest FY) | $-146.41M | — |
| Operating margin | -288.98% | — |
| Net margin | -194.88% | — |
| 52-week high | $15.02 | $42.49 |
| 52-week low | $2.75 | $22.66 |
| Distance from 52-week high | -35.46% | -35.42% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +92.67% | +49.42% |
| Average volume | 4.34M | 975.55K |
| Shares outstanding | 326.62M | 123.68M |
| Employees | 562 | 145 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About AbCellera Biologics
ABCL stock →AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 562 employees
About Parabilis Medicines
PBLS stock →Parabilis Medicines, Inc. operates as a clinical-stage biopharmaceutical company focused on developing helical peptide therapeutics for disease treatment.
Health Care · Biotechnology: Pharmaceutical Preparations · 145 employees
ABCL vs PBLS FAQ
Which is bigger, AbCellera Biologics or Parabilis Medicines?
Parabilis Medicines (PBLS) is larger, with a market capitalization of $3.44B compared with $3.16B for AbCellera Biologics (ABCL).
Are AbCellera Biologics and Parabilis Medicines in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.